Free Float 52,55 %
Shares Float 197,09 M
Shares Outstanding 375,06 M
CYXONE AB SK-,75 Share · SE0007815428 · A2AHCN (XSTO) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CYXONE AB SK-,75
No Price
Share Float & Liquidity
Company Profile for CYXONE AB SK-,75 Share
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
Company Data
Name CYXONE AB SK-,75
Company Cyxone AB (publ)
Website
https://www.cyxone.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
WKN A2AHCN
ISIN SE0007815428
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Kjell G. Stenberg
Country Sweden
Currency SEK
Employees 0,0 T
Address Adelgatan 21, 221 22 Malmö
IPO Date 2016-06-07
Stock Splits
| Date | Split |
|---|---|
| 28.12.2021 | 103:100 |
| 03.10.2018 | 547:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | CYXO.ST |
| Frankfurt | 4CX.F |
More Shares
Investors who hold CYXONE AB SK-,75 also have the following shares in their portfolio:
